Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	22.26	296.05	242.14
Graham Fair Price	13.78	10.93	9.61
PEG	-65.09	0.16	-0.46
Price/Book	15.87	0.83	0.72
Price/Cash Flow	inf	0.00	51.75
Prices/Earnings	-12.52	4.95	5.66
Price/Sales	-6.19	3.57	3.81
Price/FCF	inf	0.00	51.75
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	20.98	< 0.005	< 0.005
ROA	35.26	< 0.005	< 0.005
ROE	0.03	0.04	32.46
ROIC	< 0.005	< 0.005	121.64
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.03	1.31	-97.93
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.99	0.47	-52.21
EPS QOQ	-0.12	0.31	150.56
FCF QOQ	0.02	-1.00	5769.62
Revenue QOQ	0.54	0.22	-59.48
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	111.90	0.00	inf
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.83	0.74	-10.96
Quick Ratio	-37.27	-26.87	27.91
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	11.36	11.23	-1.14
Cash	-18.57	-16.31	12.16
Capex	0.00	0.00	0.00
Free Cash Flow	0.16	0.00	inf
Revenue	2.15	2.62	22.11
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	43.94	27.99	-36.29
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	143.32	182.20	27.13
Naive Interpretation	Member

06 - Financial Health · Bad

Rating